Table 1.
Age at enrollment (months) | |
Median (range) | 8.1 (0.7–22.1) |
Age at diagnosis (months) | |
Median (range) | 7.9 (0.7–22.0) |
Sex | |
Male | 14 (51.9%) |
Female | 13 (48.1%) |
Race | |
White | 21 (77.8%) |
Black | 2 (7.4%) |
Other | 4 (14.8%) |
Reese-Ellsworth group (n=54 eyes)* | |
II | 4 (7.4%) |
III | 8 (14.8%) |
IV | 18 (33.3%) |
V | 24 (44.4%) |
International Classification for Retinoblastoma | |
A | 2 (3.7%) |
B | 15 (27.8%) |
C | 8 (14.8%) |
D | 25 (46.3%) |
E | 4 (7.4%) |
Includes one patient who underwent enucleation of one eye (RE group VB) before enrollment.